Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » BioDiem Update and EOFY 25 Information
BioDiem Update and EOFY 25 Information
August 6, 2025 •
Category
•
Author Name
BioDiem Update and EOFY 25 Information
Latest News
2025 AGM Notice of Meeting
November 28, 2025
2025 AGM Notice of Meeting
Read More
2025 Annual Report
November 25, 2025
2025 BioDiem Limited Annual Report
Read More
